HCA Healthcare, Inc. (HCA) To Go Ex-Dividend on September 16th

Posted by George Bondi on Sep 14th, 2026

HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) declared a quarterly dividend on Thursday, July 23rd. Stockholders of record on Wednesday, September 16th will be paid a dividend of 0.78 per share on Wednesday, September 30th. This represents a c) annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th.

HCA Healthcare has raised its dividend payment by an average of 0.3%per year over the last three years and has raised its dividend annually for the last 6 consecutive years. HCA Healthcare has a dividend payout ratio of 11.1% meaning its dividend is sufficiently covered by earnings. Analysts expect HCA Healthcare to earn $32.05 per share next year, which means the company should continue to be able to cover its $3.12 annual dividend with an expected future payout ratio of 9.7%.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $427.51 on Monday. HCA Healthcare has a 1-year low of $353.99 and a 1-year high of $556.52. The firm has a market capitalization of $92.56 billion, a PE ratio of 14.31, a P/E/G ratio of 1.40 and a beta of 1.10. The business’s fifty day moving average price is $404.99 and its two-hundred day moving average price is $432.69.

HCA Healthcare (NYSE:HCA – Get Free Report) last announced its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. During the same quarter in the prior year, the firm posted $6.84 EPS. HCA Healthcare’s revenue was up 8.7% compared to the same quarter last year. Equities research analysts expect that HCA Healthcare will post 29.42 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the stock. Morgan Stanley cut their price target on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a report on Monday, July 27th. Mizuho reduced their target price on shares of HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a report on Tuesday, July 28th. JPMorgan Chase & Co. cut their price objective on HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating for the company in a research report on Thursday, August 20th. Jefferies Financial Group set a $450.00 target price on HCA Healthcare in a research report on Tuesday, July 14th. Finally, Deutsche Bank Aktiengesellschaft set a $476.00 price target on HCA Healthcare in a research note on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $462.64.

Check Out Our Latest Stock Analysis on HCA Healthcare

About HCA Healthcare

(Get Free Report)

HCA Healthcare, Inc (NYSE:HCA) is a healthcare services company that operates hospitals and other healthcare facilities. Its network provides a broad range of medical services, including emergency care, inpatient and outpatient treatment, surgery, diagnostic services, and maternity care.

The company also operates ambulatory surgery centers, urgent care facilities, physician practices, and other outpatient locations. HCA Healthcare serves patients through facilities located across the United States, as well as through HCA Healthcare UK, its healthcare operations in the United Kingdom.

HCA Healthcare was founded in 1968 by Dr.